Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitors or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Article Details
- CitationCopy to clipboard
Siragy HM
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitors or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Curr Hypertens Rep. 2003 Aug;5(4):293-4.
- PubMed ID
- 12844462 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drugs